Caroline Fontanari

Mrs. Caroline Fontanari

FCFRP USP
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2021 in Cells
Verified
Journal Article
Open access
PDF file
FZFabiana Albani Zambuzi
Fabiana Albani Zambuzi
PCPriscilla Mariane Cardoso-Silva
Priscilla Mariane Cardoso-Silva
RCRicardo Castro
Ricardo Castro
CFCaroline Fontanari
Caroline Fontanari
FEFlavio Emery
Flavio Emery
FFFabiani Frantz
Fabiani Frantz
Decitabine is an approved hypomethylating agent used for treating hematological malignancies. Although decitabine targets altered cells, epidrugs can trigger immunomodulatory effects, reinforcing the hypothesis of immunoregulation in treated patients. We therefore aimed to evaluate the impact of decitabine treatment on the phenotype and functions of monocytes and macrophages, which are pivotal cells of the innate immunity system. In vitro decitabine administration increased bacterial phagocytosis and IL-8 release, but impaired microbicidal activity of monocytes. In addition, during monocyte-to-macrophage differentiation, treatment promoted the M2-like profile, with increased expression of CD206 and ALOX15. Macrophages also demonstrated reduced infection control when exposed to Mycobacterium tuberculosis in vitro. However, cytokine production remained unchanged, indicating an atypical M2 macrophage. Furthermore, when macrophages were cocultured with lymphocytes, decitabine induced a reduction in the release of inflammatory cytokines such as IL-1β, TNF-α, and IFN-γ, maintaining IL-10 production, suggesting that decitabine could potentialize M2 polarization and might be considered as a therapeutic against the exacerbated immune response.

1 August 2016 in Experimental Parasitology
Verified
Journal Article
Closed access
GSGabriel Toffoli da Silva
Gabriel Toffoli da Silva
MEMilena Sobral Espíndola
Milena Sobral Espíndola
CFCaroline Fontanari
Caroline Fontanari
RRRogerio Silva Rosada
Rogerio Silva Rosada
LFLúcia H. Faccioli
Lúcia H. Faccioli
FFFabiani Frantz
Fabiani Frantz

29 September 2022 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
VBVitor Leonardo Bassan
Vitor Leonardo Bassan
GBGabriel Dessotti Barretto
Gabriel Dessotti Barretto
FAFelipe Campos de Almeida
Felipe Campos de Almeida
PPPatrícia Vianna Bonini Palma
Patrícia Vianna Bonini Palma
LBLarissa Sarri Binelli
Larissa Sarri Binelli
FCFabiola Castro
Fabiola Castro

5 June 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
MPMorgana Prado
Morgana Prado
CFCaroline Fontanari
Caroline Fontanari
CSCamila Souza
Camila Souza
LGLuiz Gustavo Gardinassi
Luiz Gustavo Gardinassi
KZKarina Zoccal
Karina Zoccal
LFLúcia H. Faccioli
Lúcia H. Faccioli
Histoplasma capsulatum is the agent of histoplasmosis, one of the most frequent mycoses in the world. The infection initiates with fungal spore inhalation, transformation into yeasts in the lungs and establishment of a granulomatous disease, which is characterized by a Th1 response. The production of Th1 signature cytokines, such as IFN-γ, is crucial for yeast clearance from the lungs, and to prevent dissemination. Recently, it was demonstrated that IL-17, a Th17 signature cytokine, is also important for fungal control, particularly in the absence of Th1 response. IL-22 is another cytokine with multiple functions on host response and disease progression. However, little is known about the role of IL-22 during histoplasmosis. In this study, we demonstrated that absence of IL-22 affected the clearance of yeasts from the lungs and increased the spreading to the spleen. In addition, IL-22 deficient mice (Il22−/−) succumbed to infection, which correlated with reductions in the numbers of CD4+ IFN-γ+ T cells, reduced IFN-γ levels, and diminished nitric oxide synthase type 2 (NOS2) expression in the lungs. Importantly, treatment with rIFN-γ mitigated the susceptibility of Il22−/− mice to H. capsulatum infection. These data indicate that IL-22 is crucial for IFN-γ/NO production and resistance to experimental histoplasmosis.

1 July 2024 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
NCNathalia Santos Carvalho
Nathalia Santos Carvalho
VNViviani Nardini
Viviani Nardini
RVRaul Moyses Veronezes
Raul Moyses Veronezes
Jéssica Burlamaque MacielJéssica Burlamaque Maciel
Jéssica Burlamaque Maciel
ATAmanda Cristina Trabuco
Amanda Cristina Trabuco
LFLúcia H. Faccioli
Lúcia H. Faccioli

1 October 2020 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
MMMirella dos Reis de Araújo Moreira
Mirella dos Reis de Araújo Moreira
HSHelioswilton Sales-Campos
Helioswilton Sales-Campos
CFCaroline Fontanari
Caroline Fontanari
AMAlyne Fávero Galvão Meireles
Alyne Fávero Galvão Meireles
MPMorgana Prado
Morgana Prado
LFLúcia H. Faccioli
Lúcia H. Faccioli